Effect of Single Doses of 10 mg NRL001 Applied as a Suppository to the Anal Canal or Rectum
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
Study to assess the effects of 10mg NRL001 on mean anal resting pressure (MARP) when
administered as a slow release suppository applied to the anal canal or rectum. In addition,
the pharmacokinetics of NRL001 in plasma, adverse events, and any changes in heart rate or
blood pressure were to be assessed.